27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Durham, NC, November 23, 2014 --(PR.com)-- Victor Dzau, M.D., Chancellor of the Duke University Health System, appointed Charles Stiefel as Vice Chair of the Board of Visitors and member of the 3-person Executive Committee. The Board of Visitors assists the chancellor for health affairs, senior vice chancellor for academic affairs, and the deans of the School of Medicine and School of Nursing in developing and achieving long-range goals in the priority areas of medical research, patient care, and medical education.
Accepting these appointments, Stiefel said, "Duke Medicine is one of the most outstanding health centers in the world, and I am deeply honored to be associated with this excellent institution." Charles Stiefel, who lives in Raleigh, NC, is the former Chairman and CEO of Stiefel Laboratories, a pharmaceutical company that was acquired by Glaxo SmithKline in 2009 for $3.6 billion.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Contact Information:
Charles Stiefel Philanthropy
Ann Stevens
305-495-0783
Contact via Email
www.charlesstiefelphilanthropy.org
Read the full story here: http://www.pr.com/press-release/593805
Press Release Distributed by PR.com